Dashboard
Manage Tickers

NXTCNextCure, Inc.

Nasdaq nextcure.com


$ 1.52 $ 0.03 (2.01 %)    

Friday, 03-May-2024 10:02:54 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 435.18 $ 2.86 (0.66 %)
DIA $ 386.51 $ 4.33 (1.13 %)
SPY $ 511.00 $ 0.47 (0.09 %)
TLT $ 89.64 $ -0.47 (-0.52 %)
GLD $ 212.57 $ -0.56 (-0.26 %)
$ 1.49
$ 1.52
$ 0.00 x 0
$ 0.00 x 0
$ 1.52 - $ 1.52
$ 0.98 - $ 2.57
87,557
na
41.58M
$ 0.97
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 03-21-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 03-02-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 03-03-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 03-04-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 03-12-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-12-2019 06-30-2019 10-Q
21 06-10-2019 03-31-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

nextcure-q1-eps-061-misses-059-estimate
NextCure Q1 EPS $(0.61) Misses $(0.59) Est...
05/02/2024 21:09:21

NextCure (NASDAQ:NXTC) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.59) by...

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
03/22/2024 21:33:05

hc-wainwright--co-maintains-buy-on-nextcure-raises-price-target-to-8
HC Wainwright & Co. Maintains Buy on NextC...
03/22/2024 18:16:14

HC Wainwright & Co. analyst Emily Bodnar maintains NextCure (NASDAQ:NXTC) with a Buy and raises the price target from $5...

needham-maintains-buy-on-nextcure-maintains-4-price-target
Needham Maintains Buy on NextCure, Maintai...
03/21/2024 18:59:57

Needham analyst Gil Blum maintains NextCure (NASDAQ:NXTC) with a Buy and maintains $4 price target.

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
03/21/2024 17:31:11

nextcure-expects-its-existing-cash-cash-equivalents-and-marketable-securities-will-enable-it-to-fund-operating-expenses-and-capital-expenditures-into-the-second-half-of-2026
NextCure Expects Its Existing Cash, Cash E...
03/21/2024 12:57:12

nextcure-reports-fy23-eps-225-vs-269-yoy-cash-cash-equivalents-and-marketable-securities-as-of-december-31-2023-were-1083m
NextCure Reports FY23 EPS $(2.25) Vs $(2.6...
03/21/2024 12:56:54

Financial Results for Full Year Ended December 31, 2023Cash, cash equivalents, and marketable securities as of December 31, 202...

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
03/06/2024 21:31:05

nextcure-publishes-preclinical-data-demonstrating-function-of-flrt3-as-t-cell-inhibitor-in-science-advances
NextCure Publishes Preclinical Data Demons...
03/05/2024 13:07:26

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
02/16/2024 21:31:07

nextcure-presents-preclinical-data-relating-to-novel-humanized-monoclonal-antibody-targeting-vstm-1-for-progressive-inflammatory-airway-disorders
NextCure Presents Preclinical Data Relatin...
01/18/2024 21:09:19

nextcure-published-non-clinical-data-demonstrating-nc605-an-anti-siglec-15-treatment-prevented-bone-loss-due-to-immobilization-from-acute-spinal-cord-injury
Nextcure Published Non-clinical Data Demon...
12/21/2023 12:07:06

why-amtech-systems-shares-are-trading-higher-by-over-30-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Amtech Systems Shares Are Trading High...
12/14/2023 17:56:51

Shares of Amtech Systems, Inc. (NASDAQ: ASYS) shares fell sharply during Thursday’s session after the company reported worse-t...

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
12/14/2023 17:32:05

needham-maintains-buy-on-nextcure-lowers-price-target-to-4
Needham Maintains Buy on NextCure, Lowers ...
12/14/2023 16:30:54

Needham analyst Gil Blum maintains NextCure (NASDAQ:NXTC) with a Buy and lowers the price target from $6 to $4.

us-stocks-higher-initial-jobless-claims-fall-to-202000
US Stocks Higher; Initial Jobless Claims F...
12/14/2023 14:40:47

U.S. stocks traded higher this morning, following the release of economic reports on Thursday. Following the market opening Th...

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
12/14/2023 13:07:41

nextcure-issues-year-end-clinical-pipeline-updates-says-phase-1b-combination-trial-of-nc410-with-pembrolizumab-is-ongoing-company-is-actively-seeking-strategic-partners-to-accelerate-global-development-of-programs
NextCure Issues Year-End Clinical Pipeline...
12/14/2023 11:48:42

nextcure-publishes-non-clinical-data-defining-the-mechanism-of-action-for-nc525-a-novel-lair-1-antibody-for-aml
NextCure Publishes Non-Clinical Data Defin...
11/15/2023 21:11:01

New publication in Journal of Clinical Investigation provides compelling evidence for NC525's ability to specifically kill ...

nextcure-q3-eps-051-beats-066-estimate
NextCure Q3 EPS $(0.51) Beats $(0.66) Esti...
11/02/2023 21:15:40

NextCure (NASDAQ:NXTC) reported quarterly losses of $(0.51) per share which beat the analyst consensus estimate of $(0.66) by 2...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION